We are live on ! Find out more
RP

Riverwater Partners Portfolio holdings

AUM $300M
1-Year Est. Return 26.4%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+26.4%
3 Year Est. Return
+85.45%
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
+$4.07M
Cap. Flow
+$3.06M
Cap. Flow %
1.49%
Top 10 Hldgs %
26.23%
Holding
235
New
29
Increased
97
Reduced
65
Closed
23

Sector Composition

Rank Sector Weight
1 Financials 16.75%
2 Technology 14.11%
3 Healthcare 11.23%
4 Industrials 9.56%
5 Consumer Staples 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FANG icon
201
Diamondback Energy
FANG
$56B
$230K 0.11%
1,402
-408
-23% -$71.9K
ALRS icon
202
Alerus Financial
ALRS
$828M
$229K 0.11%
10,823
-4,005
-27% -$88K
OMF icon
203
OneMain Financial
OMF
$7.27B
$228K 0.11%
+4,382
New +$227K
GDDY icon
204
GoDaddy
GDDY
$13.9B
$225K 0.11%
+1,140
New +$208K
BLDR icon
205
Builders FirstSource
BLDR
$7.29B
$225K 0.11%
+1,571
New +$278K
AEHR icon
206
Aehr Test Systems
AEHR
$2.13B
$220K 0.11%
13,241
-4,394
-25% -$58.6K
JCI icon
207
Johnson Controls International
JCI
$85.1B
$219K 0.11%
2,771
+6
+0.2% +$481
SCHB icon
208
Schwab US Broad Market ETF
SCHB
$42.3B
$215K 0.1%
9,461
-661
-7% -$15.1K
NOW icon
209
ServiceNow
NOW
$120B
$214K 0.1%
+1,010
New +$205K
IVW icon
210
iShares S&P 500 Growth ETF
IVW
$70.5B
$205K 0.1%
+2,016
New +$201K
MRSH
211
Marsh
MRSH
$94.3B
$201K 0.1%
946
-1
-0.1% -$222
UROY
212
Uranium Royalty Corp
UROY
$478M
$26.9K 0.01%
+12,281
New +$31.6K
ACGL icon
213
Arch Capital
ACGL
$36.5B
-2,073
Closed -$236K
AIT icon
214
Applied Industrial Technologies
AIT
$12.4B
-1,130
Closed -$251K
ANIK icon
215
Anika Therapeutics
ANIK
$215M
-101,996
Closed -$2.55M
ATKR icon
216
Atkore
ATKR
$2.41B
-13,456
Closed -$1.12M
CAL icon
217
Caleres
CAL
$432M
-6,866
Closed -$220K
CPRI icon
218
Capri Holdings
CPRI
$1.82B
-24,431
Closed -$1.03M
CRL icon
219
Charles River Laboratories
CRL
$11.3B
-5,643
Closed -$1.09M
DCBO
220
Docebo
DCBO
$559M
-4,703
Closed -$200K
EVR icon
221
Evercore
EVR
$11.8B
-4,447
Closed -$1.11M
HBIO icon
222
Harvard Bioscience
HBIO
$27.6M
-10,341
Closed -$265K
HDSN
223
Hudson Technologies
HDSN
$246M
-16,883
Closed -$135K
IPG
224
DELISTED
Interpublic Group of Companies
IPG
-8,225
Closed -$256K
LEU icon
225
Centrus Energy
LEU
$3.14B
-8,014
Closed -$515K

Similar funds

Riverwater Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Riverwater Partners held 235 positions worth $206M, up 2% from $201M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Riverwater Partners's Q4 2024 filing shows 29 new, 97 increased, 65 reduced and 23 closed positions. Its largest new stake was Exelixis: 57,444 shares worth $1.91M. The largest sale was Anika Therapeutics, an estimated $2.55M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Riverwater Partners's largest Q4 2024 buy was Exelixis: 57,444 shares worth $1.91M.
  • Riverwater Partners added most to Limoneira in Q4 2024, an estimated $1.49M increase.
  • Riverwater Partners's biggest Q4 2024 reduction was ICF International, cutting an estimated $1.79M.
  • Riverwater Partners fully exited Anika Therapeutics in Q4 2024, selling an estimated $2.55M.
  • Riverwater Partners's ten largest holdings make up 26% of its $206M portfolio in Q4 2024.
  • Riverwater Partners opened 29 new positions and closed 23 in Q4 2024.
  • Riverwater Partners's portfolio value rose 2% quarter-over-quarter to $206M.

Based on Riverwater Partners's 13F filing for Q4 2024, filed 13 Feb 2025.